Sheryl B. Lyss, MD; Mary L. Kamb, MD, MPH; Thomas A. Peterman, MD, MSc; John S. Moran, MD, MPH; Daniel R. Newman, MA; Gail Bolan, MD; John M. Douglas, MD; Michael Iatesta, MA; C Kevin Malotte, DrPH; Jonathan M. Zenilman, MD; Josephine Ehret, BS; Charlotte Gaydos, MS, MPH, DrPH; Wilbert J. Newhall, PhD; for the Project RESPECT Study Group*
Lyss SB, Kamb ML, Peterman TA, Moran JS, Newman DR, Bolan G, et al. Chlamydia trachomatis among Patients Infected with and Treated for Neisseria gonorrhoeae in Sexually Transmitted Disease Clinics in the United States. Ann Intern Med. 2003;139:178-185. doi: 10.7326/0003-4819-139-3-200308050-00007
Download citation file:
Published: Ann Intern Med. 2003;139(3):178-185.
In the early 1980s, shortly after techniques for culturing Chlamydia trachomatis became available, program data and expert opinion suggested that C. trachomatis coexisted in up to 45% of patients infected with Neisseria gonorrhoeae(1). On the basis of these estimates, the U.S. Centers for Disease Control and Prevention (CDC) first suggested (1) and then formally recommended (2) that all patients treated for gonorrhea should also be treated for chlamydia. Presumptive chlamydia treatment in patients treated for gonorrhea (that is, co-treatment) has remained the standard of care, a recommendation recently renewed in the CDC Sexually Transmitted Diseases Treatment Guidelines, 2002 (3).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, Sexually Transmitted Infections.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only